Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
AUTOR(ES)
Zwerschke, Werner
FONTE
The National Academy of Sciences
RESUMO
We report here that the E7 oncoprotein encoded by the oncogenic human papillomavirus (HPV) type 16 binds to the glycolytic enzyme type M2 pyruvate kinase (M2-PK). M2-PK occurs in a tetrameric form with a high affinity to its substrate phosphoenolpyruvate and a dimeric form with a low affinity to phosphoenolpyruvate, and the transition between both conformations regulates the glycolytic flux in tumor cells. The glycolytic intermediate fructose 1,6-bisphosphate induces the reassociation of the dimeric to the tetrameric form of M2-PK. The expression of E7 in an experimental cell line shifts the equilibrium to the dimeric state despite a significant increase in the fructose 1,6-bisphosphate levels. Investigations of HPV-16 E7 mutants and the nononcogenic HPV-11 subtype suggest that the interaction of HPV-16 E7 with M2-PK may be linked to the transforming potential of the viral oncoprotein.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15456Documentos Relacionados
- Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein.
- Human Papillomavirus Type 16 E7 Oncoprotein Represses Transcription of Human Fibronectin
- Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes.
- Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.
- Anchorage-Independent Transcription of the Cyclin A Gene Induced by the E7 Oncoprotein of Human Papillomavirus Type 16
